Christopher Benecchi - Feb 13, 2025 Form 4 Insider Report for Sage Therapeutics, Inc. (SAGE)

Role
Chief Operating Officer
Signature
Brandon Marsh, attorney in fact for Christopher Benecchi
Stock symbol
SAGE
Transactions as of
Feb 13, 2025
Transactions value $
-$5,902
Form type
4
Date filed
2/14/2025, 04:27 PM
Previous filing
Jan 21, 2025
Next filing
Apr 11, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SAGE Common Stock Tax liability -$5.9K -822 -1.84% $7.18 43.9K Feb 13, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On February 13, 2025, the reporting person vested 3,375 shares of time-based restricted stock units (RSUs) granted on February 13, 2024 under the Sage Therapeutics, Inc. 2014 Stock Option and Incentive Plan. This grant vests 25% on each grant anniversary date over four years. Represents shares withheld to satisfy tax withholding obligations on the vesting of restricted stock units.